Add BrightSurf on Google Email

3D printing could change how cancer drugs reach tumors

Researchers at the University of Mississippi have developed a new method for delivering cancer-fighting drugs using 3D-printed nanocarriers, which can target specific tumor sites and minimize side effects. This innovative approach has shown promising results in killing cancer cells and reducing the impact of traditional chemotherapy.

SourceUniversity of Mississippi·JournalPharmaceutical Research·DateApr 6, 2026

Researchers find way to treat lung cancer and associated muscle wasting at the same time

A new study from Oregon State University has found a way to treat both lung cancer and associated muscle-wasting cachexia using lipid nanoparticles. The treatment involves loading the nanoparticles with follistatin messenger RNA, which triggers cells to produce the protein, promoting muscle tissue growth while inhibiting tumors.

SourceOregon State University·JournalJournal of Controlled Release·TypeExperimental study·DateApr 6, 2026

New medicine piggybacks onto fat absorption pathways to allow oral delivery and support clinical trial in major depressive disorder

A new approach allows oral delivery of drugs previously requiring injection by piggybacking on natural fat absorption pathways. The medication, GlyphAllo, bypasses the liver's security checkpoint and is absorbed through the gut's lymphatic system, allowing it to enter the bloodstream directly.

SourceMonash University·JournalScience Translational Medicine·TypeRandomized controlled/clinical trial·DateMar 25, 2026

Lifesaving breakthrough in bacterial behavior

Researchers have made a groundbreaking discovery about how bacteria swim upstream to cause infections, pointing to new designs for biomedical devices that can prevent contamination. The study found that wider channels with faster counterflows are more prone to invasion, but sharp corner designs can inhibit bacterial growth.

SourceUniversity of Pennsylvania·JournalNewton·TypeExperimental study·DateJan 12, 2026

Healing the heart after a heart attack

A new patch developed by Texas A&M University researcher Dr. Ke Huang may offer a way to help the heart heal after a heart attack by delivering interleukin-4 directly to damaged heart tissue. The patch uses a microneedle system to promote repair and improve heart function without affecting the rest of the body.

SourceTexas A&M University·JournalCell Biomaterials·DateNov 19, 2025

Lipid‐based nanoplatforms: Revolutionary tools for hepatology from design to clinical challenges

Researchers have developed lipid-based nanoplatforms (LBNCs) to overcome liver disease treatment barriers, including low drug accumulation and side effects. LBNCs exhibit biocompatibility, versatile drug-loading capacity, and tunable targeting, improving therapeutic effects on fatty liver and HCC.

SourceSichuan International Medical Exchange and Promotion Association·JournalMedComm – Biomaterials and Applications·DateOct 27, 2025

New molecular map reveals how cells control traffic between the nucleus and cytoplasm

A team of scientists has created a detailed model of how cells regulate traffic through the nuclear pore complex, revealing that flexible protein chains create an entropic barrier that admits only properly escorted cargo. This breakthrough sheds light on diseases like cancer, Alzheimer's, and ALS, where this transport system fails.

SourceThe Hebrew University of Jerusalem·JournalProceedings of the National Academy of Sciences·TypeComputational simulation/modeling·DateOct 19, 2025

Human Organ Chip technology sets stage for pan-influenza A CRISPR RNA therapies

A new human lung alveolus chip model enables investigation of viral replication, inflammatory responses, and genetic off-target effects of a novel pan-influenza CRISPR therapy. The study achieved significant reductions in virus load and host inflammatory response after a single administration.

SourceWyss Institute for Biologically Inspired Engineering at Harvard·JournalLab on a Chip·TypeExperimental study·DateOct 15, 2025

The advent of nanotechnology has ushered in a transformative era for oncology, offering unprecedented capabilities for targeted drug delivery and controlled release. This paradigm shift enhances therapeutic efficacy while mitigating the debilitating side

This review highlights the potential of nanocarriers in cancer treatment, including liposomes, solid lipid nanoparticles, polymeric nanoparticles, dendrimers, and inorganic nanoparticles. The combination of these technologies with magnetic hyperthermia and viral nanoparticles offers a promising approach to treating malignant tumors.

SourceXia & He Publishing Inc.·JournalJournal of Exploratory Research in Pharmacology·DateOct 10, 2025

Possible breakthrough in the development of effective biomaterials

A research team led by Professor Shikha Dhiman has discovered that the speed of receptors in model cell membranes plays a crucial role in binding to biomaterials. When ligands move at similar speeds, they can bind to receptors, enabling effective tissue engineering and medical applications.

SourceJohannes Gutenberg Universitaet Mainz·JournalProceedings of the National Academy of Sciences·TypeObservational study·DateSep 19, 2025

Cu2+-coordinated NLG919: A drug delivery nanoplatform to activate antitumor immunity via inducing immunogenic cell death and inhibiting indoleamine 2,3-dioxygenase-1

The Cu2+-coordinated NLG919 nanoplatform induces immunogenic cell death and inhibits indoleamine 2,3-dioxygenase-1 to activate antitumor immunity. It also reverses the tumor microenvironment by blocking IDO1 inhibition.

SourceSichuan International Medical Exchange and Promotion Association·JournalMedComm – Biomaterials and Applications·DateSep 11, 2025

A novel embolization-on-a-chip model allows testing various embolic agent classes to treat liver cancer

Researchers have created a human vascularized liver cancer-on-a-chip model to evaluate vessel remodeling and cell death in response to embolic agents. This innovative platform replicates the microenvironment of liver tumors, providing unprecedented insight into how tumors respond to embolization.

SourceTerasaki Institute for Biomedical Innovation·JournalBiofabrication·TypeExperimental study·DateSep 3, 2025

CRISPR’s efficiency triples with DNA-wrapped nanoparticles

Researchers at Northwestern University have developed a new CRISPR delivery system that triples efficiency using DNA-wrapped nanoparticles, improving safety and effectiveness. The new system, called LNP-SNAs, targets specific cells and tissues, reducing toxicity and boosting gene-editing efficiency by threefold.

SourceNorthwestern University·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateSep 1, 2025